Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 14 04:00PM ET
0.1831
Dollar change
-0.0195
Percentage change
-9.62
%
Index- P/E- EPS (ttm)-4.39 Insider Own0.06% Shs Outstand10.62M Perf Week8.47%
Market Cap1.94M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float10.61M Perf Month-57.19%
Income-22.70M PEG- EPS next Q- Inst Own14.72% Short Float25.53% Perf Quarter-70.70%
Sales0.00M P/S- EPS this Y- Inst Trans2.13% Short Ratio0.14 Perf Half Y-72.26%
Book/sh-0.30 P/B- EPS next Y- ROA-158.12% Short Interest2.71M Perf Year-89.94%
Cash/sh0.14 P/C1.29 EPS next 5Y- ROE-288.27% 52W Range0.12 - 3.49 Perf YTD-61.05%
Dividend Est.- P/FCF- EPS past 5Y63.67% ROI- 52W High-94.75% Beta1.59
Dividend TTM- Quick Ratio1.30 Sales past 5Y0.00% Gross Margin- 52W Low51.32% ATR (14)0.05
Dividend Ex-Date- Current Ratio1.30 EPS Y/Y TTM64.94% Oper. Margin- RSI (14)36.68 Volatility17.88% 23.57%
Employees22 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price22.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q73.59% Payout- Rel Volume0.35 Prev Close0.20
Sales Surprise- EPS Surprise-17.54% Sales Q/Q- Earnings- Avg Volume19.28M Price0.18
SMA20-9.18% SMA50-54.99% SMA200-75.60% Trades Volume6,738,721 Change-9.62%
Date Action Analyst Rating Change Price Target Change
Jul-20-20Resumed ROTH Capital Buy $14
Jan-22-25 08:00AM
Dec-11-24 08:00AM
Dec-05-24 08:30AM
Dec-02-24 08:00AM
Nov-11-24 08:00AM
09:25AM Loading…
Sep-04-24 09:25AM
Jul-22-24 08:00AM
May-21-24 09:52PM
Apr-22-24 08:56AM
Apr-19-24 04:30PM
Apr-16-24 11:52PM
Mar-06-24 08:30AM
Feb-16-24 08:00AM
Jan-03-24 05:15PM
Dec-07-23 08:00AM
04:15PM Loading…
Nov-28-23 04:15PM
Nov-13-23 04:05PM
Nov-10-23 08:50AM
Oct-25-23 08:30AM
Sep-29-23 08:00AM
Sep-21-23 04:05PM
08:00AM
Sep-19-23 09:00AM
Sep-18-23 11:01AM
Sep-14-23 08:45AM
Sep-06-23 04:30PM
Jun-15-23 04:45PM
08:22AM
May-24-23 04:45PM
May-22-23 07:00AM
04:05PM Loading…
May-19-23 04:05PM
May-10-23 11:15AM
Apr-17-23 04:15PM
Mar-30-23 08:45AM
Mar-16-23 04:10PM
Mar-02-23 04:15PM
09:15AM
Feb-09-23 04:15PM
Jan-18-23 09:15AM
Jan-10-23 04:15PM
Jan-09-23 08:00AM
Jan-05-23 04:15PM
Dec-05-22 04:30PM
09:00AM
Nov-07-22 08:00AM
Nov-04-22 08:30AM
Nov-02-22 08:00AM
Oct-26-22 08:00AM
Oct-20-22 04:30PM
Oct-19-22 08:00AM
Sep-26-22 05:00PM
Sep-14-22 08:00AM
Sep-12-22 08:00AM
Sep-08-22 08:00AM
Aug-31-22 08:00AM
Jul-22-22 04:15PM
Jul-04-22 10:23AM
Jun-28-22 08:30AM
Jun-24-22 04:15PM
Jun-20-22 08:00AM
Jun-15-22 08:00AM
Jun-14-22 08:00AM
May-31-22 04:30PM
May-27-22 08:54AM
08:00AM
May-03-22 08:00AM
Mar-07-22 08:00AM
Feb-15-22 08:00AM
Feb-14-22 08:00AM
Jan-26-22 08:00AM
Jan-12-22 08:00AM
Jan-06-22 04:15PM
Jan-05-22 04:30PM
08:30AM
Dec-21-21 08:00AM
Nov-30-21 08:00AM
Nov-16-21 08:45AM
Nov-10-21 08:00AM
07:55AM
Nov-04-21 08:00AM
Nov-02-21 08:00AM
Oct-07-21 08:00AM
Sep-29-21 09:00AM
Sep-13-21 08:00AM
Sep-10-21 04:05PM
Aug-15-21 05:50AM
Jul-23-21 04:40PM
Jul-13-21 08:00AM
Jun-25-21 04:30PM
Jun-09-21 07:45AM
May-16-21 05:10AM
May-06-21 07:45AM
Apr-29-21 09:50AM
Mar-23-21 07:15AM
Mar-22-21 04:30PM
Mar-11-21 07:30AM
Feb-18-21 04:30PM
Feb-16-21 06:45AM
Feb-12-21 04:45PM
Feb-10-21 07:30AM
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.